cancer immunotherapy

Personalized mRNA Vaccine Shows 87% Survival Rate in Pancreatic Cancer Patients Six Years Later
|

Personalized mRNA Vaccine Shows 87% Survival Rate in Pancreatic Cancer Patients Six Years Later

Pancreatic cancer is one of the few diseases where even a diagnosis caught early enough for surgery still carries an 80 percent chance of the cancer coming back. Its five-year survival rate sits at around 13 percent. Decades of research have barely moved that number. Now, a personalized mRNA vaccine tested at Memorial Sloan Kettering…

New Cancer Injection Shrinks Metastatic Tumors Systemically
|

New Cancer Injection Shrinks Metastatic Tumors Systemically

Cancer immunotherapy has produced some of medicine’s most dramatic success stories over the past decade. But for every patient whose tumors vanish, several others see little or no benefit. One class of drugs in particular, called CD40 agonist antibodies, promised to supercharge the immune system’s ability to hunt and destroy cancer cells. For more than…

Could a Personalized mRNA Vaccine Change the Outlook for Brain Cancer?
| | |

Could a Personalized mRNA Vaccine Change the Outlook for Brain Cancer?

Glioblastoma is one of the most aggressive and devastating brain cancers, often leaving patients and families with few options. Traditional treatments—surgery, chemotherapy, and radiation—can slow the disease, but survival rates remain low. Now, researchers at the University of Florida are testing a new approach: a personalized mRNA cancer vaccine designed to reprogram the immune system…